4Moving Biotech will attend the annual conference “eCells & Materials: Cartilage and Disc Repair and Regeneration” taking place in Davos, Switzerland, from 2022, June 15th-18th. ​

Keren Bismuth, Translational Science Director at 4P-Pharma, will give a talk on the « Beneficial structural impact of Liraglutide, a GLP1 Receptor agonist, in inflammatory and post-traumatic OA animal models“, on June 15th 2022, at 3:45 pm.​

​

A poster entitled "Anti-degradative and pro-chondrogenic properties of liraglutide, a Glucagon-Like-Peptide 1 Receptor agonist: evidence from preclinical studies and implication for osteoarthritis » will also be presented during the poster sessions.​

​

Full program at: https://bit.ly/3Ofke5r